Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities.

Zhu AX, Hezel AF.

Hepatology. 2011 Feb;53(2):695-704. doi: 10.1002/hep.24145. Review.

PMID:
21274890
[PubMed - indexed for MEDLINE]
2.

Genetics of biliary tract cancers and emerging targeted therapies.

Hezel AF, Deshpande V, Zhu AX.

J Clin Oncol. 2010 Jul 20;28(21):3531-40. doi: 10.1200/JCO.2009.27.4787. Epub 2010 Jun 14. Review.

PMID:
20547994
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.

Chiorean EG, Ramasubbaiah R, Yu M, Picus J, Bufill JA, Tong Y, Coleman N, Johnston EL, Currie C, Loehrer PJ.

Oncologist. 2012;17(1):13. doi: 10.1634/theoncologist.2011-0253. Epub 2011 Dec 30.

PMID:
22210086
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Biliary tract carcinomas: from chemotherapy to targeted therapy.

Marino D, Leone F, Cavalloni G, Cagnazzo C, Aglietta M.

Crit Rev Oncol Hematol. 2013 Feb;85(2):136-48. doi: 10.1016/j.critrevonc.2012.06.006. Epub 2012 Jul 17. Review.

PMID:
22809696
[PubMed - indexed for MEDLINE]
5.

State-of-the-art in the management of locally advanced and metastatic gallbladder cancer.

McNamara MG, Metran-Nascente C, Knox JJ.

Curr Opin Oncol. 2013 Jul;25(4):425-31. doi: 10.1097/CCO.0b013e3283620fd8. Review.

PMID:
23635800
[PubMed - indexed for MEDLINE]
6.

Targeted therapy for biliary tract cancers.

Faris JE, Zhu AX.

J Hepatobiliary Pancreat Sci. 2012 Jul;19(4):326-36. doi: 10.1007/s00534-011-0496-0. Review.

PMID:
22318523
[PubMed - indexed for MEDLINE]
7.

Systemic therapy for biliary tract cancers.

Hezel AF, Zhu AX.

Oncologist. 2008 Apr;13(4):415-23. doi: 10.1634/theoncologist.2007-0252. Review.

PMID:
18448556
[PubMed - indexed for MEDLINE]
Free Article
8.

Toward personalized treatment of advanced biliary tract cancers.

Geynisman DM, Catenacci DV.

Discov Med. 2012 Jul;14(74):41-57. Review.

PMID:
22846202
[PubMed - indexed for MEDLINE]
Free Article
9.

Role of chemotherapy in treatments for biliary tract cancer.

Furuse J, Kasuga A, Takasu A, Kitamura H, Nagashima F.

J Hepatobiliary Pancreat Sci. 2012 Jul;19(4):337-41. doi: 10.1007/s00534-011-0494-2. Review.

PMID:
22456744
[PubMed - indexed for MEDLINE]
10.

Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.

Woo SM, Lee WJ, Han SS, Park SJ, Kim TH, Koh YH, Kim HB, Hong EK, Park JW, Kim CM.

Chemotherapy. 2012;58(3):225-32. doi: 10.1159/000339499. Epub 2012 Jul 21.

PMID:
22831988
[PubMed - indexed for MEDLINE]
11.

Targeted therapy in biliary tract cancer: 2009 update.

Tonini G, Virzì V, Fratto ME, Vincenzi B, Santini D.

Future Oncol. 2009 Dec;5(10):1675-84. doi: 10.2217/fon.09.130. Review.

PMID:
20001803
[PubMed - indexed for MEDLINE]
12.

Emerging treatment with systemic chemotherapy and targeted agents for biliary cancers.

Boku N.

Curr Opin Investig Drugs. 2010 Jun;11(6):653-60. Review.

PMID:
20496260
[PubMed - indexed for MEDLINE]
13.

Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma.

Park SH, Park YH, Lee JN, Bang SM, Cho EK, Shin DB, Lee JH.

Cancer. 2006 Jan 15;106(2):361-5.

PMID:
16342166
[PubMed - indexed for MEDLINE]
Free Article
15.

Photodynamic therapy for pancreatic and biliary tract cancer: the United Kingdom experience.

Pereira S.

J Natl Compr Canc Netw. 2012 Oct 1;10 Suppl 2:S48-51.

PMID:
23055216
[PubMed - indexed for MEDLINE]
16.

Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study.

André T, Reyes-Vidal JM, Fartoux L, Ross P, Leslie M, Rosmorduc O, Clemens MR, Louvet C, Perez N, Mehmud F, Scheithauer W.

Br J Cancer. 2008 Sep 16;99(6):862-7. doi: 10.1038/sj.bjc.6604628.

PMID:
19238628
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer.

Furuse J, Okusaka T, Bridgewater J, Taketsuna M, Wasan H, Koshiji M, Valle J.

Crit Rev Oncol Hematol. 2011 Oct;80(1):31-9. doi: 10.1016/j.critrevonc.2010.10.009. Epub 2010 Nov 19. Review.

PMID:
21094052
[PubMed - indexed for MEDLINE]
18.

Chemotherapy in biliary tract carcinomas: results in India.

Doval DC, Sekhon JS, Gupta SK, Gupta S, Awasthy BS.

Semin Oncol. 2002 Dec;29(6 Suppl 20):46-50. Review.

PMID:
12577233
[PubMed - indexed for MEDLINE]
19.

Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study.

Kim MJ, Oh DY, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ.

BMC Cancer. 2008 Dec 18;8:374. doi: 10.1186/1471-2407-8-374.

PMID:
19091129
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Nonsurgical therapy of biliary tract cancer.

Vazquez I, Bridgewater J.

Curr Opin Gastroenterol. 2011 May;27(3):258-61. doi: 10.1097/MOG.0b013e3283454f09. Review.

PMID:
21423009
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk